F-Star Therapeutics Agrees To $161M Sino Biopharm Takeover
F-star Therapeutics Inc., a U.K. pharma company specializing in immunotherapy, said Thursday that it has agreed to be acquired by invoX Pharma, a British subsidiary of Sino Biopharmaceutical Ltd. for $161...To view the full article, register now.
Already a subscriber? Click here to view full article